NCT00695851View on ClinicalTrials.gov

Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Prostate Cancer
Interventions
DRUG

PCK3145

i.v. bolus either 15 mg/m2 weekly of PCK3145.

DRUG

PCK3145

by i.v. bolus 7.5 mg/m2 twice per week of PCK3145

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Ambrilia Biopharma, Inc.
All Listed Sponsors
collaborator

Ambrilia Biopharma, Inc.

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00695851 - Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. | Biotech Hunter | Biotech Hunter